← Back

Biomerica Inc

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for detecting and treating medical conditions and diseases. It operates in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits that analyze blood, urine, nasal, or fecal samples to aid in diagnosing diseases, food intolerances, and other conditions, and to detect and measure bacteria, hormones, antibodies, antigens, and other substances at very low concentrations. These tests are used in clinical laboratories, point-of-care settings such as physicians' offices, and over-the-counter channels. Biomerica also provides contract development and manufacturing services, commercializes the inFoods IBS product through physician-directed and laboratory-based channels, and develops immunoassays, enzyme-linked immunosorbent assays, rapid diagnostic tests, and diagnostic-guided therapy (DGT) products for gastrointestinal diseases like irritable bowel syndrome (IBS). Its products include the EZ detect colon disease home test, the Aware Breast Self-Exam product, and hp+detect for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract. Incorporated in 1971, Biomerica is headquartered in Irvine, California.

Price · split & dividend adjusted
News & notes moving BMRA